Validation period: 9/27/2023, 12:42:51 PM - 10/4/2023, 12:42:51 PM
BMJ Journals logo
SubscribeLogin
Advancedsearch
logo
Latest contentCurrent issueArchiveBrowsePodcastsAbout
Home/Browse by collection/Adverse effects and drug safety
Email alerts

Adverse effects and drug safety

Showing results 1 - 10 of 26

Sorted by most recent

TitleAuthorDate
Safety update: NSAIDs in pregnancy

12 July 2023

Safety update: withdrawal of pholcodine-containing medicines

11 April 2023

Risk of serious adverse effects with Janus kinase inhibitors

10 January 2023

Safety update: dupilumab and ocular adverse reactions

21 December 2022

More concerns over safety of topiramate in pregnancy

11 October 2022

Dapagliflozin no longer licensed for type 1 diabetes

11 January 2022

Chloramphenicol eye drops: ok to use in children younger than 2 years

19 July 2021

Risk from concurrent opioid and benzodiazepine use

30 June 2021

Risk of DKA with SGLT2 inhibitors

2 March 2021

What is the significance of nitrosamine contamination in medicines?
David Erskine, David Wood

24 February 2021

123Next
CONTENT
  • Latest content
  • Browse by collection
  • Most read articles
  • Responses
  • Prescribing for pregnancy series
rss-icontwitter-iconfacebook-iconsoundcloud-icon
JOURNAL
  • 60 years of DTB
  • About
  • Authors
  • Editorial policies
  • Editorial board
  • Thank you to our reviewers
SUBSCRIBE
  • Subscribe
  • Email alerts
  • Log in
HELP
  • Contact us
  • Reprints
  • Permissions
  • Feedback form
bmj-footer-logo
Website Terms & ConditionsPrivacy & CookiesContact BMJCookie settingsOnline ISSN: 1755-5248 Print ISSN: 0012-6543Copyright © 2023 BMJ Publishing Group Ltd. All rights reserved.